Exploratory assessment of the key drivers of cost-effectiveness of tests used in the COVID-19 pandemic
- Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
- Total publications:2 publications
Grant number: NIHR132154
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Known Financial Commitments (USD)
$128,953.13Funder
Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)Principal Investigator
Professor Matt StevensonResearch Location
United KingdomLead Research Institution
The University of SheffieldResearch Priority Alignment
N/A
Research Category
Policies for public health, disease control & community resilience
Research Subcategory
Policy research and interventions
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The focus of this project is to undertake exploratory economic modelling of hypothetical SARS-CoV-2 viral detection point-of-care (POC) tests and serology tests, to identify the parameters that are most influential on cost-effectiveness modelling results. The assessment will include modelling of the Medicines and Healthcare products Regulatory Agency's (MHRA) target product profiles (TPP) rather than particular tests, which will allow the utility of various use cases to be explored. The TPPs outline the desired profile or characteristics of the COVID-19 tests. This assessment should help inform DHSC's, NHS England and NHS Improvement's COVID-19 diagnostic strategy, and the need for further research or audit commissioning on key data that are missing or found to be highly uncertain. The assessment will provide a framework to enable accelerated evaluation of such tests in the future for guidance development.
Publicationslinked via Europe PMC
Last Updated:2 days ago
View all publications at Europe PMC